API Holdings – CCPS B – final Lette..
Archives : September-2023
Notice is hereby given for equity shareholders of API Holdin..
Meeting Notice on 27..
PharmEasy Shareholding Pattern as on ..
Please find attached all of the Annual Reports of PharmEasy (API Holdings) Unlisted Shares that the company publishes for its shareholders to learn about the company’s business, finances, and fut..
Rights Issue Of Compulsorily Convertible Preference Shares by API Holdin..
Yes, Pharmeasy is a startup incorporated in 2015. It is India’s fastest growing online pharmacy which aims to deliver everything related to healthcare along with diagnostic services and doctor on call services. The company was founded by Dharmil Seth and Dhawal Shah. The Mumbai headquartered Pharmeasy net worth today stands at a whopping $5.4 billion. ..
Pharmeasy is in loss despite the growth in revenue and valuation. In the first quarter of the Fiscal 2022, the total loss was of Rs. 313 crore The loss of the company increased by 91% in Fiscal 2021. The company reported a loss of Rs. 641 crore in Fiscal 2021 which is almost two times ..
The valuation of Pharmeasy stands at a whopping $5 billion. The company has so far raised a total of $1.89 billion since 2015. The company is launching its IPO and aiming for a valuation of $7-8 billion. There is also some news in the market that the company is about to raise $200 million at ..
In the unlisted market, if you sell your unlisted shares within two years then investors have to pay tax which is called short-term capital gain. The short-term capital gain to be paid on Pharmeasy unlisted shares is as per investors’ normal tax slab. If the investment is for more than two years then long-term capital ..